LG
MRNA icon

LAM Group’s Moderna MRNA Stock Holding History

LAM Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$42 – 107
2024
Q4 		$42 Hold
1
– – ﹤0.01% 132
2024
Q3 		$67 Hold
1
– – ﹤0.01% 131
2024
Q2 		$119 Hold
1
– – ﹤0.01% 128
2024
Q1 		$107 Hold
1
– – ﹤0.01% 125
2023
Q4 		$99 Hold
1
– – ﹤0.01% 121
2023
Q3 		$103 Hold
1
– – ﹤0.01% 112
2023
Q2 		$122 Hold
1
– – ﹤0.01% 111
2023
Q1 		$154 Hold
1
– – ﹤0.01% 112
2022
Q4 		$180 Buy
+1
New +$164 ﹤0.01% 114

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LAM Group's MRNA Position: Q1 2025 in Review

LAM Group sold out of Moderna (MRNA) in Q1 2025, closing a stake of 1 share — an estimated $42 sold.

LAM Group first reported a position in MRNA in Q4 2022 and held it in 9 quarters. The position peaked at $180 in Q4 2022. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • LAM Group reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • LAM Group sold 1 Moderna share in Q1 2025, an estimated $42.
  • LAM Group first reported a position in Moderna in Q4 2022 and held it in 9 quarters.
  • LAM Group's Moderna position peaked at $180 in Q4 2022.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on LAM Group's 13F filing for Q1 2025, filed 16 Apr 2025.